FDx Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$471K Buy
+15,636
New +$503K 0.15% 99
2018
Q2
Sell
-36,198
Closed -$619K 1084
2018
Q1
$619K Sell
36,198
-2,667
-7% -$52.1K 0.02% 666
2017
Q4
$736K Sell
38,865
-50,920
-57% -$766K 0.02% 649
2017
Q3
$1.58M Buy
89,785
+13,658
+18% +$307K 0.04% 393
2017
Q2
$2.53M Buy
76,127
+26,472
+53% +$819K 0.07% 235
2017
Q1
$1.59M Buy
49,655
+5,987
+14% +$204K 0.05% 362
2016
Q4
$1.58M Buy
43,668
+18,075
+71% +$722K 0.05% 355
2016
Q3
$1.18M Sell
25,593
-8,247
-24% -$430K 0.05% 341
2016
Q2
$1.7M Buy
33,840
+18
+0.1% +$958 0.08% 232
2016
Q1
$1.81M Buy
33,822
+13,811
+69% +$810K 0.08% 214
2015
Q4
$1.31M Buy
20,011
+10,064
+101% +$622K 0.06% 278
2015
Q3
$562K Sell
9,947
-4,165
-30% -$270K 0.05% 414
2015
Q2
$834K Sell
14,112
-1,088
-7% -$67.1K 0.04% 388
2015
Q1
$946K Sell
15,200
-961
-6% -$55.9K 0.02% 624
2014
Q4
$929K Buy
16,161
+6,225
+63% +$347K 0.06% 329
2014
Q3
$534K Buy
+9,936
New +$526K 0.03% 560
2013
Q4
Sell
-42,101
Closed -$1.59M 668
2013
Q3
$1.59M Sell
42,101
-1,461
-3% -$57K 0.19% 117
2013
Q2
$1.71M Buy
+43,562
New +$1.7M 0.23% 105

Other funds holding TEVA